In esophageal squamous cell carcinoma cells, kindlin-2/β1 integrin/AKT signaling activation promotes tumor invasion13; in prostate cancer cell lines, inhibition of the kindlin-2/β1 integrin pathway enhances the sensitivity to chemotherapeutic agents14. The gene discussed is FERMT2; the disease is prostate cancer.